Krsnaa Diagnostics Board of Directors

Get the latest insights into the leadership at Krsnaa Diagnostics. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Rajendra Mutha Chairman & Wholetime Director
Mr. Yash Mutha Managing Director
Ms. Pallavi Bhatevara Whole Time Director
Mr. Adesh Kumar Gupta Independent Director
Mr. Rajiva Ranjan Verma Independent Director
Mr. Chetan Desai Independent Director
Ms. Chhaya Palrecha Independent Director
Mr. Prem Pradeep Nominee Director

Krsnaa Diagnostics Share price

KRSNAA

832.45

2.95 (0.36%)
NSE
BSE
Last updated on 15 Oct, 2025 | 15:43 IST
BUYSELL
Today's High

848.10

Today's Low

813.65

52 Week Low

625.75

52 Week High

1044.00

The current prices are delayed, login to your account for live prices

Krsnaa Diagnostics FAQs

The board at Krsnaa Diagnostics consists of experienced professionals, including Mr. Rajendra Mutha , Mr. Yash Mutha , and others, overseeing the company’s strategic and corporate governance.

Directors at Krsnaa Diagnostics are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Rajendra Mutha is the current chairman at Krsnaa Diagnostics.

Executive directors at Krsnaa Diagnostics are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Krsnaa Diagnostics adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Krsnaa Diagnostics, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.